Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer.

Koussounadis A, Langdon SP, Harrison DJ, Smith VA.

Br J Cancer. 2014 Jun 10;110(12):2975-84. doi: 10.1038/bjc.2014.258. Epub 2014 May 27.

PMID:
24867692
[PubMed - indexed for MEDLINE]
2.

Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer.

Koti M, Gooding RJ, Nuin P, Haslehurst A, Crane C, Weberpals J, Childs T, Bryson P, Dharsee M, Evans K, Feilotter HE, Park PC, Squire JA.

BMC Cancer. 2013 Nov 16;13:549. doi: 10.1186/1471-2407-13-549.

PMID:
24237932
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.

Ferriss JS, Kim Y, Duska L, Birrer M, Levine DA, Moskaluk C, Theodorescu D, Lee JK.

PLoS One. 2012;7(2):e30550. doi: 10.1371/journal.pone.0030550. Epub 2012 Feb 10.

PMID:
22348014
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
[PubMed - indexed for MEDLINE]
6.

Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.

Okamoto A, Nikaido T, Ochiai K, Takakura S, Saito M, Aoki Y, Ishii N, Yanaihara N, Yamada K, Takikawa O, Kawaguchi R, Isonishi S, Tanaka T, Urashima M.

Clin Cancer Res. 2005 Aug 15;11(16):6030-9.

PMID:
16115948
[PubMed - indexed for MEDLINE]
Free Article
7.

Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer.

Horio M, Kato T, Mii S, Enomoto A, Asai M, Asai N, Murakumo Y, Shibata K, Kikkawa F, Takahashi M.

Cancer Med. 2012 Oct;1(2):218-29. doi: 10.1002/cam4.32. Epub 2012 Sep 13.

PMID:
23342271
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.

Tong L, Chen W, Wu J, Li H.

Anticancer Drugs. 2014 Mar;25(3):244-54. doi: 10.1097/CAD.0000000000000047.

PMID:
24275314
[PubMed - indexed for MEDLINE]
9.

The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.

Witham J, Valenti MR, De-Haven-Brandon AK, Vidot S, Eccles SA, Kaye SB, Richardson A.

Clin Cancer Res. 2007 Dec 1;13(23):7191-8.

PMID:
18056200
[PubMed - indexed for MEDLINE]
Free Article
10.

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.

Ricciardelli C, Ween MP, Lokman NA, Tan IA, Pyragius CE, Oehler MK.

BMC Cancer. 2013 Oct 14;13:476. doi: 10.1186/1471-2407-13-476.

PMID:
24124770
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.

Osterberg L, Levan K, Partheen K, Staaf J, Sundfeldt K, Horvath G.

Cytogenet Genome Res. 2009;125(1):8-18. doi: 10.1159/000218744. Epub 2009 Jul 14.

PMID:
19617691
[PubMed - indexed for MEDLINE]
12.

Medical therapy of advanced malignant epithelial tumours of the ovary.

Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.

Forum (Genova). 2000 Oct-Dec;10(4):323-32. Review.

PMID:
11535983
[PubMed - indexed for MEDLINE]
13.

[Alteration of survivin gene expression in ovarian cancer cell line CAOV3 after chemotherapy in vitro].

Zhang SL, Jiang T, Lin B, Zhao CQ, Meng LR.

Zhonghua Fu Chan Ke Za Zhi. 2004 Jul;39(7):482-5. Chinese.

PMID:
15347474
[PubMed - indexed for MEDLINE]
14.

Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.

Sugimura M, Sagae S, Ishioka S, Nishioka Y, Tsukada K, Kudo R.

Oncology. 2004;66(1):53-61.

PMID:
15031599
[PubMed - indexed for MEDLINE]
15.

Clinical implications of REST and TUBB3 in ovarian cancer and its relationship to paclitaxel resistance.

Gao S, Zhao X, Lin B, Hu Z, Yan L, Gao J.

Tumour Biol. 2012 Oct;33(5):1759-65. doi: 10.1007/s13277-012-0435-y. Epub 2012 Jun 10.

PMID:
22684772
[PubMed - indexed for MEDLINE]
16.

Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.

Fichtner I, Rolff J, Soong R, Hoffmann J, Hammer S, Sommer A, Becker M, Merk J.

Clin Cancer Res. 2008 Oct 15;14(20):6456-68. doi: 10.1158/1078-0432.CCR-08-0138.

PMID:
18927285
[PubMed - indexed for MEDLINE]
Free Article
17.

Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications.

Gadducci A, Cosio S, Muraca S, Genazzani AR.

Eur J Gynaecol Oncol. 2002;23(5):390-6. Review.

PMID:
12440809
[PubMed - indexed for MEDLINE]
18.

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth.

Marchion DC, Bicaku E, Xiong Y, Bou Zgheib N, Al Sawah E, Stickles XB, Judson PL, Lopez AS, Cubitt CL, Gonzalez-Bosquet J, Wenham RM, Apte SM, Berglund A, Lancaster JM.

Oncol Rep. 2013 May;29(5):2011-8. doi: 10.3892/or.2013.2329. Epub 2013 Mar 5.

PMID:
23467907
[PubMed - indexed for MEDLINE]
19.

Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin.

Komiyama S, Kurahashi T, Ishikawa M, Tanaka K, Komiyama M, Mikami M, Udagawa Y.

Oncol Rep. 2011 Apr;25(4):1131-8. doi: 10.3892/or.2011.1151. Epub 2011 Jan 18.

PMID:
21249319
[PubMed - indexed for MEDLINE]
20.

Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma.

Gillet JP, Calcagno AM, Varma S, Davidson B, Bunkholt Elstrand M, Ganapathi R, Kamat AA, Sood AK, Ambudkar SV, Seiden MV, Rueda BR, Gottesman MM.

Clin Cancer Res. 2012 Jun 1;18(11):3197-206. doi: 10.1158/1078-0432.CCR-12-0056. Epub 2012 Apr 5.

PMID:
22492981
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk